paul
Paul Van Damme, MBA, CPA, CA
Managing Director

Paul joined Wildlaw Capital Markets in 2011 as a Managing Director with a focus on providing CFO-level financial and strategic services to public companies in order to provide a full service solution to our clients.

Paul has served in senior financial roles for a number of public companies in both the United States and Canada. He held a number of increasingly responsible positions while at Canada Systems Group, culminating in his appointment as Chief Financial Officer in 1988. In 1991, Paul joined Laidlaw Inc. and helped implement their expansion into Europe. After three years as Chief Financial Officer of TeleZone Inc., a start-up wireless telecommunications company, he joined a private biotech company and helped raise venture financing to expand their product portfolio. Paul later joined Allelix Pharmaceuticals Inc. and participated in the sale of the company to NPS Pharmaceuticals, Inc. He currently provides part-time CFO services to Structural Genomics Consortium and is Managing Director of WCM Capital. Paul received his undergraduate degree (B.Comm.) from the University of Toronto and his M.B.A. from the Rotman School of Management. He is a Chartered Professional Accountant and articled with PricewaterhouseCoopers where he served as Audit Manager in London, England and Toronto, Canada. He currently serves as a director of Quest PharmaTech Inc.

Paul received his undergraduate degree (B.Comm.) from the University of Toronto and his MBA from the Rotman School of Management. He is a Chartered Accountant and articled with PricewaterhouseCoopers where he served as Audit Manager in London, England and Toronto, Canada. He’s currently on the Board of Directors at Quest PharmaTech Inc. and at Insception Biosciences Inc.

P: 416-847-6905
pvandamme